nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—Chest discomfort—Capecitabine—esophageal cancer	0.00401	0.00719	CcSEcCtD
Oxybutynin—Skin discolouration—Capecitabine—esophageal cancer	0.00393	0.00704	CcSEcCtD
Oxybutynin—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00393	0.00704	CcSEcCtD
Oxybutynin—Oropharyngeal pain—Capecitabine—esophageal cancer	0.0039	0.007	CcSEcCtD
Oxybutynin—Nasal congestion—Cisplatin—esophageal cancer	0.00383	0.00688	CcSEcCtD
Oxybutynin—Nocturia—Capecitabine—esophageal cancer	0.00382	0.00686	CcSEcCtD
Oxybutynin—Lung disorder—Methotrexate—esophageal cancer	0.00373	0.00669	CcSEcCtD
Oxybutynin—Amnesia—Cisplatin—esophageal cancer	0.00372	0.00667	CcSEcCtD
Oxybutynin—Blood pressure increased—Capecitabine—esophageal cancer	0.00355	0.00636	CcSEcCtD
Oxybutynin—Hiccups—Capecitabine—esophageal cancer	0.00355	0.00636	CcSEcCtD
Oxybutynin—Melaena—Capecitabine—esophageal cancer	0.00346	0.00622	CcSEcCtD
Oxybutynin—Fungal infection—Methotrexate—esophageal cancer	0.00342	0.00613	CcSEcCtD
Oxybutynin—Colitis—Capecitabine—esophageal cancer	0.00341	0.00611	CcSEcCtD
Oxybutynin—Face oedema—Cisplatin—esophageal cancer	0.00337	0.00605	CcSEcCtD
Oxybutynin—Fluid retention—Capecitabine—esophageal cancer	0.00337	0.00604	CcSEcCtD
Oxybutynin—Dry eye—Capecitabine—esophageal cancer	0.00328	0.00588	CcSEcCtD
Oxybutynin—Blood creatinine increased—Cisplatin—esophageal cancer	0.00327	0.00587	CcSEcCtD
Oxybutynin—Oesophagitis—Capecitabine—esophageal cancer	0.00324	0.00581	CcSEcCtD
Oxybutynin—Mouth ulceration—Capecitabine—esophageal cancer	0.00321	0.00575	CcSEcCtD
Oxybutynin—Breast disorder—Cisplatin—esophageal cancer	0.00316	0.00566	CcSEcCtD
Oxybutynin—Nasopharyngitis—Cisplatin—esophageal cancer	0.00312	0.0056	CcSEcCtD
Oxybutynin—Abnormal vision—Capecitabine—esophageal cancer	0.00309	0.00555	CcSEcCtD
Oxybutynin—Mental disability—Capecitabine—esophageal cancer	0.00308	0.00552	CcSEcCtD
Oxybutynin—Sleep disorder—Capecitabine—esophageal cancer	0.00297	0.00534	CcSEcCtD
Oxybutynin—Skin discolouration—Methotrexate—esophageal cancer	0.00292	0.00524	CcSEcCtD
Oxybutynin—Abdominal discomfort—Cisplatin—esophageal cancer	0.00289	0.00519	CcSEcCtD
Oxybutynin—Glossitis—Methotrexate—esophageal cancer	0.00286	0.00514	CcSEcCtD
Oxybutynin—Eye pain—Capecitabine—esophageal cancer	0.00285	0.00512	CcSEcCtD
Oxybutynin—Libido decreased—Capecitabine—esophageal cancer	0.00278	0.00498	CcSEcCtD
Oxybutynin—Hot flush—Capecitabine—esophageal cancer	0.00275	0.00494	CcSEcCtD
Oxybutynin—Increased appetite—Capecitabine—esophageal cancer	0.00274	0.00492	CcSEcCtD
Oxybutynin—Amnesia—Capecitabine—esophageal cancer	0.00274	0.00492	CcSEcCtD
Oxybutynin—Menopausal symptoms—Capecitabine—esophageal cancer	0.00273	0.00489	CcSEcCtD
Oxybutynin—Thirst—Capecitabine—esophageal cancer	0.00271	0.00485	CcSEcCtD
Oxybutynin—Dermatitis bullous—Capecitabine—esophageal cancer	0.00269	0.00483	CcSEcCtD
Oxybutynin—Arthritis—Capecitabine—esophageal cancer	0.00265	0.00475	CcSEcCtD
Oxybutynin—Stomatitis—Cisplatin—esophageal cancer	0.00262	0.00471	CcSEcCtD
Oxybutynin—Conjunctivitis—Cisplatin—esophageal cancer	0.00262	0.00469	CcSEcCtD
Oxybutynin—Cystitis noninfective—Methotrexate—esophageal cancer	0.00258	0.00463	CcSEcCtD
Oxybutynin—Melaena—Methotrexate—esophageal cancer	0.00258	0.00463	CcSEcCtD
Oxybutynin—Osteoarthritis—Capecitabine—esophageal cancer	0.00257	0.00462	CcSEcCtD
Oxybutynin—Pain in extremity—Capecitabine—esophageal cancer	0.00257	0.00462	CcSEcCtD
Oxybutynin—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.00255	0.00458	CcSEcCtD
Oxybutynin—Cystitis—Methotrexate—esophageal cancer	0.00255	0.00457	CcSEcCtD
Oxybutynin—Migraine—Capecitabine—esophageal cancer	0.00253	0.00455	CcSEcCtD
Oxybutynin—Face oedema—Capecitabine—esophageal cancer	0.00249	0.00446	CcSEcCtD
Oxybutynin—Urinary retention—Capecitabine—esophageal cancer	0.00245	0.00439	CcSEcCtD
Oxybutynin—Mood swings—Capecitabine—esophageal cancer	0.00244	0.00438	CcSEcCtD
Oxybutynin—Blood creatinine increased—Capecitabine—esophageal cancer	0.00241	0.00433	CcSEcCtD
Oxybutynin—Bladder pain—Methotrexate—esophageal cancer	0.00239	0.00428	CcSEcCtD
Oxybutynin—Mouth ulceration—Methotrexate—esophageal cancer	0.00239	0.00428	CcSEcCtD
Oxybutynin—Urinary tract disorder—Cisplatin—esophageal cancer	0.00239	0.00428	CcSEcCtD
Oxybutynin—Liver function test abnormal—Capecitabine—esophageal cancer	0.00238	0.00426	CcSEcCtD
Oxybutynin—Connective tissue disorder—Cisplatin—esophageal cancer	0.00237	0.00426	CcSEcCtD
Oxybutynin—Urethral disorder—Cisplatin—esophageal cancer	0.00237	0.00425	CcSEcCtD
Oxybutynin—Dry skin—Capecitabine—esophageal cancer	0.00236	0.00423	CcSEcCtD
Oxybutynin—Abdominal pain upper—Capecitabine—esophageal cancer	0.00235	0.00422	CcSEcCtD
Oxybutynin—Visual impairment—Cisplatin—esophageal cancer	0.00233	0.00418	CcSEcCtD
Oxybutynin—Breast disorder—Capecitabine—esophageal cancer	0.00233	0.00417	CcSEcCtD
Oxybutynin—Nasopharyngitis—Capecitabine—esophageal cancer	0.0023	0.00413	CcSEcCtD
Oxybutynin—Eye disorder—Cisplatin—esophageal cancer	0.00226	0.00405	CcSEcCtD
Oxybutynin—Tinnitus—Cisplatin—esophageal cancer	0.00225	0.00404	CcSEcCtD
Oxybutynin—Cardiac disorder—Cisplatin—esophageal cancer	0.00224	0.00402	CcSEcCtD
Oxybutynin—Flushing—Cisplatin—esophageal cancer	0.00224	0.00402	CcSEcCtD
Oxybutynin—Abdominal distension—Capecitabine—esophageal cancer	0.00224	0.00402	CcSEcCtD
Oxybutynin—Asthma—Capecitabine—esophageal cancer	0.00223	0.00399	CcSEcCtD
Oxybutynin—Influenza—Capecitabine—esophageal cancer	0.00223	0.00399	CcSEcCtD
Oxybutynin—Dysphagia—Capecitabine—esophageal cancer	0.00223	0.00399	CcSEcCtD
Oxybutynin—Mediastinal disorder—Cisplatin—esophageal cancer	0.00218	0.00391	CcSEcCtD
Oxybutynin—Arrhythmia—Cisplatin—esophageal cancer	0.00216	0.00387	CcSEcCtD
Oxybutynin—Bronchitis—Capecitabine—esophageal cancer	0.00214	0.00384	CcSEcCtD
Oxybutynin—Abdominal discomfort—Capecitabine—esophageal cancer	0.00213	0.00383	CcSEcCtD
Oxybutynin—Erythema—Cisplatin—esophageal cancer	0.0021	0.00377	CcSEcCtD
Oxybutynin—Malnutrition—Cisplatin—esophageal cancer	0.0021	0.00377	CcSEcCtD
Oxybutynin—Dysuria—Capecitabine—esophageal cancer	0.00208	0.00373	CcSEcCtD
Oxybutynin—Flatulence—Cisplatin—esophageal cancer	0.00207	0.00372	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Capecitabine—esophageal cancer	0.00207	0.00371	CcSEcCtD
Oxybutynin—Infestation NOS—Capecitabine—esophageal cancer	0.00198	0.00356	CcSEcCtD
Oxybutynin—Infestation—Capecitabine—esophageal cancer	0.00198	0.00356	CcSEcCtD
Oxybutynin—Vision blurred—Cisplatin—esophageal cancer	0.00198	0.00356	CcSEcCtD
Oxybutynin—Depression—Capecitabine—esophageal cancer	0.00198	0.00355	CcSEcCtD
Oxybutynin—Ill-defined disorder—Cisplatin—esophageal cancer	0.00195	0.0035	CcSEcCtD
Oxybutynin—Stomatitis—Capecitabine—esophageal cancer	0.00193	0.00347	CcSEcCtD
Oxybutynin—Urinary tract infection—Capecitabine—esophageal cancer	0.00193	0.00346	CcSEcCtD
Oxybutynin—Conjunctivitis—Capecitabine—esophageal cancer	0.00193	0.00346	CcSEcCtD
Oxybutynin—Osteoarthritis—Methotrexate—esophageal cancer	0.00192	0.00344	CcSEcCtD
Oxybutynin—Malaise—Cisplatin—esophageal cancer	0.0019	0.0034	CcSEcCtD
Oxybutynin—Haematuria—Capecitabine—esophageal cancer	0.00189	0.00339	CcSEcCtD
Oxybutynin—Epistaxis—Capecitabine—esophageal cancer	0.00187	0.00336	CcSEcCtD
Oxybutynin—Convulsion—Cisplatin—esophageal cancer	0.00182	0.00327	CcSEcCtD
Oxybutynin—Mood swings—Methotrexate—esophageal cancer	0.00182	0.00326	CcSEcCtD
Oxybutynin—Rhinitis—Capecitabine—esophageal cancer	0.00179	0.0032	CcSEcCtD
Oxybutynin—Anxiety—Cisplatin—esophageal cancer	0.00178	0.0032	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.00178	0.00319	CcSEcCtD
Oxybutynin—Hypoaesthesia—Capecitabine—esophageal cancer	0.00177	0.00318	CcSEcCtD
Oxybutynin—Liver function test abnormal—Methotrexate—esophageal cancer	0.00177	0.00317	CcSEcCtD
Oxybutynin—Discomfort—Cisplatin—esophageal cancer	0.00177	0.00317	CcSEcCtD
Oxybutynin—Pharyngitis—Capecitabine—esophageal cancer	0.00177	0.00317	CcSEcCtD
Oxybutynin—Urinary tract disorder—Capecitabine—esophageal cancer	0.00176	0.00316	CcSEcCtD
Oxybutynin—Oedema peripheral—Capecitabine—esophageal cancer	0.00175	0.00315	CcSEcCtD
Oxybutynin—Connective tissue disorder—Capecitabine—esophageal cancer	0.00175	0.00314	CcSEcCtD
Oxybutynin—Urethral disorder—Capecitabine—esophageal cancer	0.00175	0.00313	CcSEcCtD
Oxybutynin—Breast disorder—Methotrexate—esophageal cancer	0.00173	0.00311	CcSEcCtD
Oxybutynin—Anaphylactic shock—Cisplatin—esophageal cancer	0.00172	0.00308	CcSEcCtD
Oxybutynin—Oedema—Cisplatin—esophageal cancer	0.00172	0.00308	CcSEcCtD
Oxybutynin—Visual impairment—Capecitabine—esophageal cancer	0.00172	0.00308	CcSEcCtD
Oxybutynin—Infection—Cisplatin—esophageal cancer	0.00171	0.00306	CcSEcCtD
Oxybutynin—Nervous system disorder—Cisplatin—esophageal cancer	0.00168	0.00302	CcSEcCtD
Oxybutynin—Tachycardia—Cisplatin—esophageal cancer	0.00168	0.00301	CcSEcCtD
Oxybutynin—Skin disorder—Cisplatin—esophageal cancer	0.00167	0.00299	CcSEcCtD
Oxybutynin—Eye disorder—Capecitabine—esophageal cancer	0.00166	0.00299	CcSEcCtD
Oxybutynin—Tinnitus—Capecitabine—esophageal cancer	0.00166	0.00298	CcSEcCtD
Oxybutynin—Asthma—Methotrexate—esophageal cancer	0.00166	0.00297	CcSEcCtD
Oxybutynin—Cardiac disorder—Capecitabine—esophageal cancer	0.00165	0.00297	CcSEcCtD
Oxybutynin—Flushing—Capecitabine—esophageal cancer	0.00165	0.00297	CcSEcCtD
Oxybutynin—Anorexia—Cisplatin—esophageal cancer	0.00164	0.00294	CcSEcCtD
Oxybutynin—Angiopathy—Capecitabine—esophageal cancer	0.00162	0.0029	CcSEcCtD
Oxybutynin—Mediastinal disorder—Capecitabine—esophageal cancer	0.00161	0.00288	CcSEcCtD
Oxybutynin—Hypotension—Cisplatin—esophageal cancer	0.0016	0.00288	CcSEcCtD
Oxybutynin—Arrhythmia—Capecitabine—esophageal cancer	0.00159	0.00285	CcSEcCtD
Oxybutynin—Abdominal discomfort—Methotrexate—esophageal cancer	0.00159	0.00285	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00156	0.00281	CcSEcCtD
Oxybutynin—Mental disorder—Capecitabine—esophageal cancer	0.00156	0.0028	CcSEcCtD
Oxybutynin—Erythema—Capecitabine—esophageal cancer	0.00155	0.00278	CcSEcCtD
Oxybutynin—Malnutrition—Capecitabine—esophageal cancer	0.00155	0.00278	CcSEcCtD
Oxybutynin—Dysuria—Methotrexate—esophageal cancer	0.00155	0.00278	CcSEcCtD
Oxybutynin—Paraesthesia—Cisplatin—esophageal cancer	0.00154	0.00277	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Methotrexate—esophageal cancer	0.00154	0.00276	CcSEcCtD
Oxybutynin—Flatulence—Capecitabine—esophageal cancer	0.00153	0.00274	CcSEcCtD
Oxybutynin—Erectile dysfunction—Methotrexate—esophageal cancer	0.00153	0.00274	CcSEcCtD
Oxybutynin—Dysgeusia—Capecitabine—esophageal cancer	0.00152	0.00272	CcSEcCtD
Oxybutynin—Back pain—Capecitabine—esophageal cancer	0.0015	0.00269	CcSEcCtD
Oxybutynin—Decreased appetite—Cisplatin—esophageal cancer	0.00149	0.00268	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.00148	0.00266	CcSEcCtD
Oxybutynin—Infestation NOS—Methotrexate—esophageal cancer	0.00148	0.00265	CcSEcCtD
Oxybutynin—Infestation—Methotrexate—esophageal cancer	0.00148	0.00265	CcSEcCtD
Oxybutynin—Drowsiness—Methotrexate—esophageal cancer	0.00148	0.00265	CcSEcCtD
Oxybutynin—Depression—Methotrexate—esophageal cancer	0.00147	0.00264	CcSEcCtD
Oxybutynin—Pain—Cisplatin—esophageal cancer	0.00147	0.00263	CcSEcCtD
Oxybutynin—Vision blurred—Capecitabine—esophageal cancer	0.00146	0.00262	CcSEcCtD
Oxybutynin—Stomatitis—Methotrexate—esophageal cancer	0.00144	0.00258	CcSEcCtD
Oxybutynin—Ill-defined disorder—Capecitabine—esophageal cancer	0.00144	0.00258	CcSEcCtD
Oxybutynin—Conjunctivitis—Methotrexate—esophageal cancer	0.00144	0.00258	CcSEcCtD
Oxybutynin—Feeling abnormal—Cisplatin—esophageal cancer	0.00141	0.00254	CcSEcCtD
Oxybutynin—Haematuria—Methotrexate—esophageal cancer	0.00141	0.00253	CcSEcCtD
Oxybutynin—Malaise—Capecitabine—esophageal cancer	0.0014	0.00251	CcSEcCtD
Oxybutynin—Epistaxis—Methotrexate—esophageal cancer	0.00139	0.0025	CcSEcCtD
Oxybutynin—Syncope—Capecitabine—esophageal cancer	0.00139	0.00249	CcSEcCtD
Oxybutynin—Palpitations—Capecitabine—esophageal cancer	0.00137	0.00246	CcSEcCtD
Oxybutynin—Loss of consciousness—Capecitabine—esophageal cancer	0.00136	0.00244	CcSEcCtD
Oxybutynin—Cough—Capecitabine—esophageal cancer	0.00135	0.00243	CcSEcCtD
Oxybutynin—Hypertension—Capecitabine—esophageal cancer	0.00134	0.0024	CcSEcCtD
Oxybutynin—Chest pain—Capecitabine—esophageal cancer	0.00132	0.00237	CcSEcCtD
Oxybutynin—Arthralgia—Capecitabine—esophageal cancer	0.00132	0.00237	CcSEcCtD
Oxybutynin—Pharyngitis—Methotrexate—esophageal cancer	0.00132	0.00236	CcSEcCtD
Oxybutynin—Anxiety—Capecitabine—esophageal cancer	0.00132	0.00236	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.00131	0.00235	CcSEcCtD
Oxybutynin—Urinary tract disorder—Methotrexate—esophageal cancer	0.00131	0.00235	CcSEcCtD
Oxybutynin—Discomfort—Capecitabine—esophageal cancer	0.0013	0.00234	CcSEcCtD
Oxybutynin—Urethral disorder—Methotrexate—esophageal cancer	0.0013	0.00233	CcSEcCtD
Oxybutynin—Dry mouth—Capecitabine—esophageal cancer	0.00129	0.00232	CcSEcCtD
Oxybutynin—Visual impairment—Methotrexate—esophageal cancer	0.00128	0.00229	CcSEcCtD
Oxybutynin—Confusional state—Capecitabine—esophageal cancer	0.00128	0.00229	CcSEcCtD
Oxybutynin—Oedema—Capecitabine—esophageal cancer	0.00127	0.00227	CcSEcCtD
Oxybutynin—Hypersensitivity—Cisplatin—esophageal cancer	0.00126	0.00227	CcSEcCtD
Oxybutynin—Infection—Capecitabine—esophageal cancer	0.00126	0.00226	CcSEcCtD
Oxybutynin—Shock—Capecitabine—esophageal cancer	0.00124	0.00223	CcSEcCtD
Oxybutynin—Nervous system disorder—Capecitabine—esophageal cancer	0.00124	0.00223	CcSEcCtD
Oxybutynin—Eye disorder—Methotrexate—esophageal cancer	0.00124	0.00222	CcSEcCtD
Oxybutynin—Tinnitus—Methotrexate—esophageal cancer	0.00124	0.00222	CcSEcCtD
Oxybutynin—Tachycardia—Capecitabine—esophageal cancer	0.00123	0.00222	CcSEcCtD
Oxybutynin—Asthenia—Cisplatin—esophageal cancer	0.00123	0.00221	CcSEcCtD
Oxybutynin—Cardiac disorder—Methotrexate—esophageal cancer	0.00123	0.00221	CcSEcCtD
Oxybutynin—Skin disorder—Capecitabine—esophageal cancer	0.00123	0.0022	CcSEcCtD
Oxybutynin—Anorexia—Capecitabine—esophageal cancer	0.00121	0.00216	CcSEcCtD
Oxybutynin—Angiopathy—Methotrexate—esophageal cancer	0.0012	0.00216	CcSEcCtD
Oxybutynin—Mediastinal disorder—Methotrexate—esophageal cancer	0.00119	0.00214	CcSEcCtD
Oxybutynin—Hypotension—Capecitabine—esophageal cancer	0.00118	0.00212	CcSEcCtD
Oxybutynin—Diarrhoea—Cisplatin—esophageal cancer	0.00117	0.00211	CcSEcCtD
Oxybutynin—Mental disorder—Methotrexate—esophageal cancer	0.00116	0.00208	CcSEcCtD
Oxybutynin—Malnutrition—Methotrexate—esophageal cancer	0.00115	0.00207	CcSEcCtD
Oxybutynin—Erythema—Methotrexate—esophageal cancer	0.00115	0.00207	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00115	0.00207	CcSEcCtD
Oxybutynin—Insomnia—Capecitabine—esophageal cancer	0.00114	0.00205	CcSEcCtD
Oxybutynin—Paraesthesia—Capecitabine—esophageal cancer	0.00114	0.00204	CcSEcCtD
Oxybutynin—Dysgeusia—Methotrexate—esophageal cancer	0.00113	0.00203	CcSEcCtD
Oxybutynin—Back pain—Methotrexate—esophageal cancer	0.00112	0.002	CcSEcCtD
Oxybutynin—Dyspepsia—Capecitabine—esophageal cancer	0.00111	0.002	CcSEcCtD
Oxybutynin—Decreased appetite—Capecitabine—esophageal cancer	0.0011	0.00197	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.00109	0.00196	CcSEcCtD
Oxybutynin—Vomiting—Cisplatin—esophageal cancer	0.00109	0.00196	CcSEcCtD
Oxybutynin—Fatigue—Capecitabine—esophageal cancer	0.00109	0.00196	CcSEcCtD
Oxybutynin—Vision blurred—Methotrexate—esophageal cancer	0.00109	0.00195	CcSEcCtD
Oxybutynin—Rash—Cisplatin—esophageal cancer	0.00108	0.00194	CcSEcCtD
Oxybutynin—Pain—Capecitabine—esophageal cancer	0.00108	0.00194	CcSEcCtD
Oxybutynin—Constipation—Capecitabine—esophageal cancer	0.00108	0.00194	CcSEcCtD
Oxybutynin—Dermatitis—Cisplatin—esophageal cancer	0.00108	0.00194	CcSEcCtD
Oxybutynin—Ill-defined disorder—Methotrexate—esophageal cancer	0.00107	0.00192	CcSEcCtD
Oxybutynin—Feeling abnormal—Capecitabine—esophageal cancer	0.00104	0.00187	CcSEcCtD
Oxybutynin—Malaise—Methotrexate—esophageal cancer	0.00104	0.00187	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00103	0.00186	CcSEcCtD
Oxybutynin—Nausea—Cisplatin—esophageal cancer	0.00102	0.00183	CcSEcCtD
Oxybutynin—Cough—Methotrexate—esophageal cancer	0.00101	0.00181	CcSEcCtD
Oxybutynin—Urticaria—Capecitabine—esophageal cancer	0.00101	0.0018	CcSEcCtD
Oxybutynin—Abdominal pain—Capecitabine—esophageal cancer	0.001	0.00179	CcSEcCtD
Oxybutynin—Convulsion—Methotrexate—esophageal cancer	0.001	0.00179	CcSEcCtD
Oxybutynin—Chest pain—Methotrexate—esophageal cancer	0.000983	0.00176	CcSEcCtD
Oxybutynin—Arthralgia—Methotrexate—esophageal cancer	0.000983	0.00176	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000976	0.00175	CcSEcCtD
Oxybutynin—Discomfort—Methotrexate—esophageal cancer	0.000971	0.00174	CcSEcCtD
Oxybutynin—Confusional state—Methotrexate—esophageal cancer	0.00095	0.0017	CcSEcCtD
Oxybutynin—Anaphylactic shock—Methotrexate—esophageal cancer	0.000942	0.00169	CcSEcCtD
Oxybutynin—Infection—Methotrexate—esophageal cancer	0.000936	0.00168	CcSEcCtD
Oxybutynin—Hypersensitivity—Capecitabine—esophageal cancer	0.000932	0.00167	CcSEcCtD
Oxybutynin—Nervous system disorder—Methotrexate—esophageal cancer	0.000924	0.00166	CcSEcCtD
Oxybutynin—Skin disorder—Methotrexate—esophageal cancer	0.000915	0.00164	CcSEcCtD
Oxybutynin—Asthenia—Capecitabine—esophageal cancer	0.000908	0.00163	CcSEcCtD
Oxybutynin—Anorexia—Methotrexate—esophageal cancer	0.000898	0.00161	CcSEcCtD
Oxybutynin—Pruritus—Capecitabine—esophageal cancer	0.000895	0.00161	CcSEcCtD
Oxybutynin—Hypotension—Methotrexate—esophageal cancer	0.00088	0.00158	CcSEcCtD
Oxybutynin—Diarrhoea—Capecitabine—esophageal cancer	0.000866	0.00155	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000858	0.00154	CcSEcCtD
Oxybutynin—Insomnia—Methotrexate—esophageal cancer	0.000852	0.00153	CcSEcCtD
Oxybutynin—Paraesthesia—Methotrexate—esophageal cancer	0.000846	0.00152	CcSEcCtD
Oxybutynin—Somnolence—Methotrexate—esophageal cancer	0.000837	0.0015	CcSEcCtD
Oxybutynin—Dizziness—Capecitabine—esophageal cancer	0.000837	0.0015	CcSEcCtD
Oxybutynin—Dyspepsia—Methotrexate—esophageal cancer	0.000829	0.00149	CcSEcCtD
Oxybutynin—Decreased appetite—Methotrexate—esophageal cancer	0.000819	0.00147	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000813	0.00146	CcSEcCtD
Oxybutynin—Fatigue—Methotrexate—esophageal cancer	0.000812	0.00146	CcSEcCtD
Oxybutynin—Pain—Methotrexate—esophageal cancer	0.000805	0.00145	CcSEcCtD
Oxybutynin—Vomiting—Capecitabine—esophageal cancer	0.000805	0.00144	CcSEcCtD
Oxybutynin—Rash—Capecitabine—esophageal cancer	0.000798	0.00143	CcSEcCtD
Oxybutynin—Dermatitis—Capecitabine—esophageal cancer	0.000797	0.00143	CcSEcCtD
Oxybutynin—Headache—Capecitabine—esophageal cancer	0.000793	0.00142	CcSEcCtD
Oxybutynin—Feeling abnormal—Methotrexate—esophageal cancer	0.000776	0.00139	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00077	0.00138	CcSEcCtD
Oxybutynin—Nausea—Capecitabine—esophageal cancer	0.000752	0.00135	CcSEcCtD
Oxybutynin—Urticaria—Methotrexate—esophageal cancer	0.000748	0.00134	CcSEcCtD
Oxybutynin—Abdominal pain—Methotrexate—esophageal cancer	0.000745	0.00134	CcSEcCtD
Oxybutynin—Hypersensitivity—Methotrexate—esophageal cancer	0.000694	0.00125	CcSEcCtD
Oxybutynin—Asthenia—Methotrexate—esophageal cancer	0.000676	0.00121	CcSEcCtD
Oxybutynin—Pruritus—Methotrexate—esophageal cancer	0.000666	0.0012	CcSEcCtD
Oxybutynin—Diarrhoea—Methotrexate—esophageal cancer	0.000644	0.00116	CcSEcCtD
Oxybutynin—Dizziness—Methotrexate—esophageal cancer	0.000623	0.00112	CcSEcCtD
Oxybutynin—Vomiting—Methotrexate—esophageal cancer	0.000599	0.00107	CcSEcCtD
Oxybutynin—Rash—Methotrexate—esophageal cancer	0.000594	0.00107	CcSEcCtD
Oxybutynin—Dermatitis—Methotrexate—esophageal cancer	0.000593	0.00106	CcSEcCtD
Oxybutynin—Headache—Methotrexate—esophageal cancer	0.00059	0.00106	CcSEcCtD
Oxybutynin—Nausea—Methotrexate—esophageal cancer	0.000559	0.001	CcSEcCtD
Oxybutynin—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000156	0.000353	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—AKAP13—esophageal cancer	0.000156	0.000352	CbGpPWpGaD
Oxybutynin—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—esophageal cancer	0.000156	0.000352	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—AKAP13—esophageal cancer	0.000155	0.000351	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—AKAP13—esophageal cancer	0.000154	0.000347	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SST—esophageal cancer	0.000153	0.000346	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ALDH2—esophageal cancer	0.000151	0.000342	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALDOB—esophageal cancer	0.00015	0.000338	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TYMP—esophageal cancer	0.00015	0.000338	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—GHRL—esophageal cancer	0.000149	0.000338	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOTCH3—esophageal cancer	0.000149	0.000338	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—FBXW7—esophageal cancer	0.000147	0.000332	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PLCE1—esophageal cancer	0.000147	0.000331	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADH7—esophageal cancer	0.000147	0.000331	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP26A1—esophageal cancer	0.000145	0.000329	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GAPDH—esophageal cancer	0.000144	0.000326	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—GSTT1—esophageal cancer	0.000144	0.000325	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000144	0.000325	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000143	0.000324	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CRABP1—esophageal cancer	0.000143	0.000323	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PDE4D—esophageal cancer	0.000142	0.000322	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP2A6—esophageal cancer	0.000142	0.000322	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PDE4D—esophageal cancer	0.000142	0.000321	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000142	0.000321	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALOX15—esophageal cancer	0.000142	0.00032	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PDE4D—esophageal cancer	0.000141	0.000318	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GNG7—esophageal cancer	0.000136	0.000307	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—GNG7—esophageal cancer	0.000136	0.000306	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—TPI1—esophageal cancer	0.000135	0.000306	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTO1—esophageal cancer	0.000135	0.000306	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—GNG7—esophageal cancer	0.000135	0.000305	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ENO1—esophageal cancer	0.000135	0.000305	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS1—esophageal cancer	0.000135	0.000305	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOTCH2—esophageal cancer	0.000134	0.000303	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—GNG7—esophageal cancer	0.000134	0.000302	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PSME1—esophageal cancer	0.000133	0.0003	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PSME2—esophageal cancer	0.000133	0.0003	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC52A3—esophageal cancer	0.000132	0.000299	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—BLVRB—esophageal cancer	0.000132	0.000299	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALDOB—esophageal cancer	0.00013	0.000293	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ADH1B—esophageal cancer	0.000128	0.00029	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ALDH2—esophageal cancer	0.000127	0.000288	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—XIAP—esophageal cancer	0.000127	0.000287	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—XIAP—esophageal cancer	0.000127	0.000286	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—XIAP—esophageal cancer	0.000125	0.000283	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GAPDH—esophageal cancer	0.000125	0.000282	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CRABP1—esophageal cancer	0.000124	0.000279	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TYMP—esophageal cancer	0.000123	0.000277	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—GSTT1—esophageal cancer	0.000121	0.000274	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CTNNA1—esophageal cancer	0.00012	0.000271	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CTNNA1—esophageal cancer	0.00012	0.00027	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP2A6—esophageal cancer	0.00012	0.00027	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP26A1—esophageal cancer	0.000119	0.00027	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CXCL2—esophageal cancer	0.000119	0.00027	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CXCL2—esophageal cancer	0.000119	0.000269	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TGFBR2—esophageal cancer	0.000119	0.000269	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CTNNA1—esophageal cancer	0.000119	0.000268	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CXCL2—esophageal cancer	0.000118	0.000266	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GNG7—esophageal cancer	0.000118	0.000266	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALOX15—esophageal cancer	0.000116	0.000263	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP1B1—esophageal cancer	0.000115	0.000259	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS1—esophageal cancer	0.000113	0.000256	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ENO1—esophageal cancer	0.000113	0.000256	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—SLC10A2—esophageal cancer	0.000113	0.000255	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CA1—esophageal cancer	0.000113	0.000255	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—SMAD4—esophageal cancer	0.000113	0.000254	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PSME1—esophageal cancer	0.000112	0.000253	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PSME2—esophageal cancer	0.000112	0.000253	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PSME1—esophageal cancer	0.000112	0.000252	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PSME2—esophageal cancer	0.000112	0.000252	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PSME1—esophageal cancer	0.000111	0.000251	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PSME2—esophageal cancer	0.000111	0.000251	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—TPI1—esophageal cancer	0.000111	0.000251	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTO1—esophageal cancer	0.000111	0.000251	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ANXA1—esophageal cancer	0.000111	0.000251	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ANXA1—esophageal cancer	0.000111	0.00025	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ALDH2—esophageal cancer	0.00011	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PSME2—esophageal cancer	0.00011	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PSME1—esophageal cancer	0.00011	0.000249	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ANXA1—esophageal cancer	0.00011	0.000248	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SST—esophageal cancer	0.000108	0.000244	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CYP19A1—esophageal cancer	0.000108	0.000244	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SST—esophageal cancer	0.000108	0.000243	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SST—esophageal cancer	0.000107	0.000241	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALDOB—esophageal cancer	0.000106	0.000241	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH3—esophageal cancer	0.000105	0.000238	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—GHRL—esophageal cancer	0.000105	0.000238	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—GHRL—esophageal cancer	0.000105	0.000237	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH3—esophageal cancer	0.000105	0.000237	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—GSTT1—esophageal cancer	0.000105	0.000237	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—GHRL—esophageal cancer	0.000104	0.000235	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH3—esophageal cancer	0.000104	0.000235	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP2A6—esophageal cancer	0.000104	0.000234	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—FBXW7—esophageal cancer	0.000104	0.000234	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000103	0.000233	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—FBXW7—esophageal cancer	0.000103	0.000233	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CA2—esophageal cancer	0.000103	0.000233	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GAPDH—esophageal cancer	0.000102	0.000232	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—FBXW7—esophageal cancer	0.000102	0.000231	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CRABP1—esophageal cancer	0.000102	0.000229	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—HMOX1—esophageal cancer	9.84e-05	0.000222	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ENO1—esophageal cancer	9.83e-05	0.000222	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS1—esophageal cancer	9.83e-05	0.000222	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PSME2—esophageal cancer	9.68e-05	0.000219	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PSME1—esophageal cancer	9.68e-05	0.000219	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GNG7—esophageal cancer	9.66e-05	0.000218	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP1B1—esophageal cancer	9.65e-05	0.000218	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADH7—esophageal cancer	9.58e-05	0.000216	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PLCE1—esophageal cancer	9.58e-05	0.000216	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—ABCB1—esophageal cancer	9.45e-05	0.000213	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH2—esophageal cancer	9.44e-05	0.000213	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH2—esophageal cancer	9.41e-05	0.000213	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH2—esophageal cancer	9.32e-05	0.00021	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—HIF1A—esophageal cancer	9.21e-05	0.000208	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CYP19A1—esophageal cancer	9.07e-05	0.000205	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ALDH2—esophageal cancer	9.05e-05	0.000205	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—KDR—esophageal cancer	8.81e-05	0.000199	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—GSTT1—esophageal cancer	8.61e-05	0.000195	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP2A6—esophageal cancer	8.51e-05	0.000192	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	8.46e-05	0.000191	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ADH1B—esophageal cancer	8.4e-05	0.00019	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TGFBR2—esophageal cancer	8.37e-05	0.000189	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP1B1—esophageal cancer	8.36e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TGFBR2—esophageal cancer	8.35e-05	0.000189	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOTCH1—esophageal cancer	8.3e-05	0.000187	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—HMOX1—esophageal cancer	8.28e-05	0.000187	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TGFBR2—esophageal cancer	8.26e-05	0.000187	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ENO1—esophageal cancer	8.07e-05	0.000182	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS1—esophageal cancer	8.07e-05	0.000182	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TYMP—esophageal cancer	8.03e-05	0.000181	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PSME2—esophageal cancer	7.95e-05	0.00018	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PSME1—esophageal cancer	7.95e-05	0.00018	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—ABCB1—esophageal cancer	7.94e-05	0.000179	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—SMAD4—esophageal cancer	7.93e-05	0.000179	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—SMAD4—esophageal cancer	7.9e-05	0.000178	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CYP19A1—esophageal cancer	7.86e-05	0.000178	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—SMAD4—esophageal cancer	7.82e-05	0.000177	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP26A1—esophageal cancer	7.81e-05	0.000176	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALOX15—esophageal cancer	7.61e-05	0.000172	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CREBBP—esophageal cancer	7.52e-05	0.00017	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—EGFR—esophageal cancer	7.39e-05	0.000167	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTO1—esophageal cancer	7.26e-05	0.000164	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—TPI1—esophageal cancer	7.26e-05	0.000164	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—HMOX1—esophageal cancer	7.17e-05	0.000162	CbGpPWpGaD
Oxybutynin—CHRM5—GPCR downstream signaling—PIK3CA—esophageal cancer	7.06e-05	0.00016	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	7.03e-05	0.000159	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDOB—esophageal cancer	6.96e-05	0.000157	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—ABCB1—esophageal cancer	6.88e-05	0.000155	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP1B1—esophageal cancer	6.86e-05	0.000155	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—NOS3—esophageal cancer	6.74e-05	0.000152	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GAPDH—esophageal cancer	6.7e-05	0.000151	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CRABP1—esophageal cancer	6.64e-05	0.00015	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—HIF1A—esophageal cancer	6.48e-05	0.000147	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—HIF1A—esophageal cancer	6.46e-05	0.000146	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CYP19A1—esophageal cancer	6.45e-05	0.000146	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling by GPCR—PIK3CA—esophageal cancer	6.42e-05	0.000145	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—HIF1A—esophageal cancer	6.4e-05	0.000145	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GNG7—esophageal cancer	6.32e-05	0.000143	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—CREBBP—esophageal cancer	6.31e-05	0.000143	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—ERBB2—esophageal cancer	6.3e-05	0.000142	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—KDR—esophageal cancer	6.2e-05	0.00014	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—KDR—esophageal cancer	6.18e-05	0.00014	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—KDR—esophageal cancer	6.12e-05	0.000138	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ALDH2—esophageal cancer	5.92e-05	0.000134	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—HMOX1—esophageal cancer	5.89e-05	0.000133	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOTCH1—esophageal cancer	5.84e-05	0.000132	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOTCH1—esophageal cancer	5.82e-05	0.000132	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOTCH1—esophageal cancer	5.77e-05	0.00013	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—NOS3—esophageal cancer	5.65e-05	0.000128	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—ABCB1—esophageal cancer	5.65e-05	0.000128	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—GSTT1—esophageal cancer	5.63e-05	0.000127	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CCND1—esophageal cancer	5.57e-05	0.000126	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP2A6—esophageal cancer	5.56e-05	0.000126	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—CDKN1A—esophageal cancer	5.38e-05	0.000122	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—CREBBP—esophageal cancer	5.31e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CREBBP—esophageal cancer	5.3e-05	0.00012	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CREBBP—esophageal cancer	5.28e-05	0.000119	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ENO1—esophageal cancer	5.27e-05	0.000119	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS1—esophageal cancer	5.27e-05	0.000119	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CREBBP—esophageal cancer	5.23e-05	0.000118	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—EGFR—esophageal cancer	5.2e-05	0.000118	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	5.2e-05	0.000118	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSME1—esophageal cancer	5.2e-05	0.000117	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PSME2—esophageal cancer	5.2e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—EGFR—esophageal cancer	5.19e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PTGS2—esophageal cancer	5.17e-05	0.000117	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—EGFR—esophageal cancer	5.14e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EP300—esophageal cancer	5.12e-05	0.000116	CbGpPWpGaD
Oxybutynin—CHRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	4.97e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM3—GPCR downstream signaling—PIK3CA—esophageal cancer	4.96e-05	0.000112	CbGpPWpGaD
Oxybutynin—CHRM2—GPCR downstream signaling—PIK3CA—esophageal cancer	4.91e-05	0.000111	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—NOS3—esophageal cancer	4.75e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—NOS3—esophageal cancer	4.74e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—NOS3—esophageal cancer	4.73e-05	0.000107	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—NOS3—esophageal cancer	4.68e-05	0.000106	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—CREBBP—esophageal cancer	4.6e-05	0.000104	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling by GPCR—PIK3CA—esophageal cancer	4.52e-05	0.000102	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling by GPCR—PIK3CA—esophageal cancer	4.5e-05	0.000102	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP1B1—esophageal cancer	4.49e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—MYC—esophageal cancer	4.46e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling by GPCR—PIK3CA—esophageal cancer	4.46e-05	0.000101	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—ERBB2—esophageal cancer	4.44e-05	0.0001	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—ERBB2—esophageal cancer	4.42e-05	9.99e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—ERBB2—esophageal cancer	4.38e-05	9.89e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—EGFR—esophageal cancer	4.37e-05	9.87e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PTGS2—esophageal cancer	4.35e-05	9.82e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—EP300—esophageal cancer	4.3e-05	9.72e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CYP19A1—esophageal cancer	4.22e-05	9.53e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—NOS3—esophageal cancer	4.12e-05	9.3e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CCND1—esophageal cancer	3.92e-05	8.85e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CCND1—esophageal cancer	3.91e-05	8.83e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CCND1—esophageal cancer	3.87e-05	8.74e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—HMOX1—esophageal cancer	3.85e-05	8.69e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—CDKN1A—esophageal cancer	3.79e-05	8.57e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—PIK3CA—esophageal cancer	3.79e-05	8.56e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—CDKN1A—esophageal cancer	3.78e-05	8.54e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—CREBBP—esophageal cancer	3.78e-05	8.53e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PTGS2—esophageal cancer	3.77e-05	8.51e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—CDKN1A—esophageal cancer	3.74e-05	8.46e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—ABCB1—esophageal cancer	3.69e-05	8.34e-05	CbGpPWpGaD
Oxybutynin—CHRM5—Signaling Pathways—TP53—esophageal cancer	3.67e-05	8.28e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—EP300—esophageal cancer	3.62e-05	8.17e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EP300—esophageal cancer	3.61e-05	8.15e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EP300—esophageal cancer	3.6e-05	8.12e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EP300—esophageal cancer	3.56e-05	8.05e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—NOS3—esophageal cancer	3.38e-05	7.64e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Metabolism—PIK3CA—esophageal cancer	3.18e-05	7.19e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—MYC—esophageal cancer	3.14e-05	7.1e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—MYC—esophageal cancer	3.13e-05	7.08e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—EP300—esophageal cancer	3.13e-05	7.08e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—MYC—esophageal cancer	3.1e-05	7.01e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PTGS2—esophageal cancer	3.09e-05	6.99e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—EGFR—esophageal cancer	3.07e-05	6.95e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—EGFR—esophageal cancer	3.06e-05	6.92e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—EGFR—esophageal cancer	3.04e-05	6.86e-05	CbGpPWpGaD
Oxybutynin—CYP3A5—Metabolism—PIK3CA—esophageal cancer	2.68e-05	6.04e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—PIK3CA—esophageal cancer	2.67e-05	6.03e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—PIK3CA—esophageal cancer	2.66e-05	6.01e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—PIK3CA—esophageal cancer	2.63e-05	5.95e-05	CbGpPWpGaD
Oxybutynin—CHRM1—Signaling Pathways—TP53—esophageal cancer	2.58e-05	5.83e-05	CbGpPWpGaD
Oxybutynin—CHRM3—Signaling Pathways—TP53—esophageal cancer	2.57e-05	5.81e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—EP300—esophageal cancer	2.57e-05	5.81e-05	CbGpPWpGaD
Oxybutynin—CHRM2—Signaling Pathways—TP53—esophageal cancer	2.55e-05	5.76e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—CREBBP—esophageal cancer	2.47e-05	5.58e-05	CbGpPWpGaD
Oxybutynin—CYP2C8—Metabolism—PIK3CA—esophageal cancer	2.32e-05	5.23e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—NOS3—esophageal cancer	2.21e-05	4.99e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PTGS2—esophageal cancer	2.02e-05	4.57e-05	CbGpPWpGaD
Oxybutynin—CYP2D6—Metabolism—PIK3CA—esophageal cancer	1.9e-05	4.3e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—EP300—esophageal cancer	1.68e-05	3.8e-05	CbGpPWpGaD
Oxybutynin—CYP3A4—Metabolism—PIK3CA—esophageal cancer	1.24e-05	2.81e-05	CbGpPWpGaD
